TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - PFIZER INC Stock

Certificat

DE000SV1FPT7

Delayed Deutsche Boerse AG 07:04:19 2024-07-11 am EDT
2.28 EUR -4.60% Intraday chart for TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - PFIZER INC
Current month-2.05%
1 month-0.83%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-11 2.28 -4.60%
24-07-10 2.39 -2.45%
24-07-09 2.45 +1.24%
24-07-08 2.42 +0.41%
24-07-05 2.41 0.00%

Delayed Quote Deutsche Boerse AG

Last update July 11, 2024 at 07:04 am EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying PFIZER, INC.
IssuerLogo Issuer Société Générale Société Générale
WKN SV1FPT
ISINDE000SV1FPT7
Date issued 2023-02-24
Strike 54.1 $
Maturity Unlimited
Parity 10 : 1
Emission price 1.25
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.74
Lowest since issue 1.23
Spread 0.02
Spread %0.86%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
28.35 USD
Average target price
32.01 USD
Spread / Average Target
+12.90%
Consensus